Connect with us


VIDEO: Dani Alves fights Hepatitis C in Egypt

Photo by Valerio Pennicino/Getty Images

Photo by Valerio Pennicino/Getty Images

Juventus defender has been involved in the Egyptian Tour n’ Cure campaign to fight Hepatitis C and boost tourism in .

The Brazilian has been involved as an ambassador with the Tour n’ Cure campaign aimed to eradicate Hepatitis C that has plagued Egypt for ages.

“I chose to stand for a world free of Hepatitis C,” said Alves.

So what is Tour n’ Cure ? according to their official website they “provide hepatitis C patients, from all over the world, with an effective and affordable treatment package. It is Egypt’s latest initiative in medical tourism—namely offering the opportunity to treat hepatitis C with the most recent, advanced therapies worldwide, with no waiting time.”

Their package also includes the “opportunity to take in the beauty of Egypt and visit historic landmarks during the days of the treatment, while enjoying a relaxing stay at a 5-star hotel.”

The highly decorated 33-year-old Brazilian who just joined Juventus this season has been involved with the campaign as an ambassador.

“Thousands of people have been cured by receiving medical care in one of the most beautiful destinations in the world, Egypt.

“Hepatitis C virus is now curable and I, Dani Alves chose to help people for a world free of Hepatitis C.” said the Juventus defender.

Egypt has one of the world’s highest hepatitis burdens. According to the World Health Organisation, it is estimated that 10% of the ‎population between 15 and ‎‎59 years is chronically ‎infected with hepatitis C. In 2014 the WHO released a statistic confirming that HCV kills an estimated 40,000 Egyptians a year. Every year there are 170,000 to 200,000 new HCV cases. Egypt has been experiencing an decrease in Hepatitis C occurrence since last year after the admission of Sofosbuvir which has helped cure the case.

Watch the campaign video:


Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *



More in News